SCHEMBL5363840

SCHEMBL5363840

O=c1ccc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2Cl)[nH]1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 4/20 0.45
SRD5A2 P31213 1/20 0.43
F11 P03951 1/20 0.42
AHR P35869 1/20 0.42
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
GCGR P47871 1/20 0.41
MAPK14 Q16539 1/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPT P10636 2/20 0.41
MARS1 P56192 1/20 0.40
KDM4E B2RXH2 2/20 0.40
HSD11B1 P28845 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
GAA P10253 1/20 0.40
THRB P10828 1/20 0.40
TSHR P16473 1/20 0.40
HCAR1 Q9BXC0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2933108 0.75 AHR (0.67) SRD5A2AHRALDH1A1MARS1KDM4E
SCHEMBL5358142 0.75 SRD5A2 (0.49) SRD5A2CNR1MAPK14ALDH1A1MARS1
SCHEMBL1404496 0.75 CNR1 (0.49) CNR1CNR2ALDH1A1KDM4EGAA
SCHEMBL4553075 0.74 F11 (0.56) SRD5A2F11AHRALDH1A1MAPT
SCHEMBL4553459 0.73 F11 (0.68) SRD5A2F11AHRMEN1KMT2A
SCHEMBL10899871 0.72 MAP4K4 (0.49) SRD5A2AHRALDH1A1MAPTMARS1
SCHEMBL5358072 0.71 CNR1 (0.50) CNR1CNR2MAPTKDM4E
SCHEMBL4552133 0.69 F11 (0.62) F11ALDH1A1MAPTKDM4EMEN1
SCHEMBL3475271 0.67 AHR (0.50) SRD5A2AHRALDH1A1MAPTMARS1
SCHEMBL7046189 0.67 HSD11B1 (0.47) CNR1CNR2GCGRMAPK14ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7271266-B2 Substituted 2,3-diphenyl pyridines MERCK & CO., INC. (US) 2007-09-18 US disclosed
US-20050182103-A1 Substituted 2,3-diphenyl pyridines MERCK SHARP & DOHME CORP. 2005-08-18 US disclosed
EP-1492784-A2 SUBSTITUTED 2,3-DIPHENYL PYRIDINES Merck & Co., Inc. (US) 2005-01-05 EP disclosed
WO-2003082191-A2 SUBSTITUTED 2,3-DIPHENYL PYRIDINES MERCK & CO., INC. (US) 2003-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182103-A1 Substituted 2,3-diphenyl pyridines CNR1, CNR2, MAG PDE10A 1793/4885SRD5A2 4833/4885F11 3406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.